5.5 billion yuan, of which Ernst & Young invested a total of 55 million yuan in January and August 2013, accounting for 21.56% of the shares. These two time points coincided with the time when investors revealed that the investors subscribed for "Lianwenji. Jin" twice. In April 2013, Jiuchuan Investment nominated Hu Min to become the director of Yunsheng Medical. According to the recruitment materials of the Union Bank series of private equity funds, Hu Min has been involved in structured financing for many years. In 2006, he was invited to participate in the purchase and listing of Yunsheng Industrial (the predecessor of Yunsheng Medical). : k In December 2013, Yunsheng Industrial launched a plan to issue shares to purchase assets: it plans to issue shares to Jiuchuan Investment and Bain (Tianjin) Investment Management Co., Ltd. (hereinafter referred to as "Bain Investment") to purchase two holdings. Some Tianjin Jiusheng Investment Development Co., Ltd. (hereinafter referred to as "Jiusheng Investment") 100% equity public materials show that Jiusheng Investment was established in 2008 and was originally a wholly-owned subsidiary of Jiuchuan Investment. At the end of 2012, Bain Capital increased its capital to Jiusheng Investment for 20 million yuan. In 2013, Bain Capital increased its capital to Jiusheng Investment in cash several times. By the end of the last capital increase in August 2013, Bain Capital eventually became a shareholder. Monetary invested 219 million yuan in capital and obtained 47.78% of the equity of Jiusheng Investment.